Top compounds associated with response to MED12L


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.1 0.02
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.094 0.02
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.077 0.03
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.078 0.03
mRNA phenformin GDSC1000 pan-cancer AAC 0.072 0.03
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.03
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC 0.26 0.03
mRNA LAQ824 GDSC1000 pan-cancer AAC 0.078 0.03
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.075 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.03
Download CSV